isradipine has been researched along with Cognitive Decline in 1 studies
Isradipine: A potent antagonist of CALCIUM CHANNELS that is highly selective for VASCULAR SMOOTH MUSCLE. It is effective in the treatment of chronic stable angina pectoris, hypertension, and congestive cardiac failure.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mills, KA | 1 |
| Schneider, RB | 1 |
| Saint-Hilaire, M | 1 |
| Ross, GW | 1 |
| Hauser, RA | 1 |
| Lang, AE | 1 |
| Halverson, MJ | 1 |
| Oakes, D | 1 |
| Eberly, S | 1 |
| Litvan, I | 1 |
| Blindauer, K | 1 |
| Aquino, C | 1 |
| Simuni, T | 1 |
| Marras, C | 1 |
1 trial available for isradipine and Cognitive Decline
| Article | Year |
|---|---|
Cognitive impairment in Parkinson's disease: Associations between subjective and objective cognitive decline in a large longitudinal study.
Topics: Aged; Calcium Channel Blockers; Cognitive Dysfunction; Depression; Diagnostic Self Evaluation; Execu | 2020 |